Purchase Order HHSN261201700725P

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $24,158.08 on October 19, 2017, with an ultimate completion date of November 19, 2018. Performance occurs at Bethesda, Maryland. The order is firm fixed price with no set-aside designation. Specific requirements are not detailed in the source material.</p>

<p>The National Cancer Institute awarded a purchase order to Ultraview Corporation valued at $9,995.00 on July 27, 2017. Work is performed at Bethesda, Maryland. The order carries a firm fixed price and ultimate completion date of August 20, 2017. No set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $17,948.50 on September 19, 2019, for drugs and biologicals, with ultimate completion on October 19, 2019. Place of performance is Bethesda, Maryland. The order uses firm fixed-price pricing with no set-aside category.</p>

<p>The National Cancer Institute awarded a purchase order to Beckman Coulter, Inc. for $7,814.50 on December 27, 2017, with an ultimate completion date of January 28, 2019. Performance occurs at Bethesda, Maryland. The order is priced on a firm fixed price basis. No set-aside was applied.</p>

<p>The National Cancer Institute awarded a purchase order to Trustees of Indiana University for $5,114.95 on April 5, 2018, with completion scheduled for May 5, 2018. Performance occurs at Bethesda, Maryland. The order is firm fixed price with no set-aside designation. The solicitation identifier is 18-022903.</p>

<p>The National Cancer Institute awarded a purchase order to Noldus Information Technology, Inc. for $14,797.00 on September 8, 2017, with ultimate completion on September 7, 2018. Performance occurs in Bethesda, Maryland. The order is fixed-price with economic price adjustment and carries no small business set-aside. The source does not specify the particular equipment, software, or services procured under this order.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $12,768.84 on September 11, 2018, with completion scheduled for September 18, 2019. Pricing is fixed-price with economic price adjustment. Place of performance is Bethesda, Maryland. The source does not identify the specific items or services procured under this order.</p>

<p>The National Cancer Institute awarded a purchase order to Northeastern University valued at $19,345.00 on May 15, 2020, for professional services. Place of performance is Bethesda, Maryland. The order carries a firm fixed-price structure with an ultimate completion date of December 31, 2020. No set-aside was used.</p>

<p>The National Cancer Institute issued a purchase order to EPL Pathology Archives, LLC valued at $13,798.64 on June 10, 2019, for a service agreement. Place of performance is Bethesda, Maryland. The order carries a firm fixed price structure with no small business set-aside. The ultimate completion date is August 31, 2019.</p>

<p>The National Cancer Institute awarded a purchase order to Media Cybernetics Inc., a small disadvantaged business, valued at $14,985.00 on August 14, 2017. Performance is scheduled for completion by September 15, 2018, at Bethesda, Maryland. The order is firm fixed price with no small business set-aside. The source does not specify the particular products or services being procured.</p>